Martapan 2mg/5ml oral solution Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

martapan 2mg/5ml oral solution

martindale pharmaceuticals ltd - dexamethasone sodium phosphate - oral solution - 400microgram/1ml

Aripiprazole 1mg/ml oral solution Airija - anglų - HPRA (Health Products Regulatory Authority)

aripiprazole 1mg/ml oral solution

wockhardt uk limited - aripiprazole - oral solution - 1 milligram(s)/millilitre - other antipsychotics; aripiprazole - other antipsychotics - aripiprazole is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. aripiprazole is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment

APO-OLANZAPINE ODT olanzapine 10 mg orally disintegrating tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

apo-olanzapine odt olanzapine 10 mg orally disintegrating tablet blister pack

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 10 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; mannitol; sucralose; carmellose calcium - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

APO-OLANZAPINE ODT olanzapine 5 mg orally disintegrating tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

apo-olanzapine odt olanzapine 5 mg orally disintegrating tablet blister pack

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 5 mg - tablet, orally disintegrating - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; carmellose calcium; sucralose; mannitol - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

APO-OLANZAPINE ODT olanzapine 15 mg orally disintegrating tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

apo-olanzapine odt olanzapine 15 mg orally disintegrating tablet blister pack

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 15 mg - tablet, orally disintegrating - excipient ingredients: carmellose calcium; sucralose; mannitol; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.